ADAM17 at the interface between inflammation and autoimmunity

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Disintegrin and metalloproteinase 17 (ADAM17), also known as tumor necrosis factor-alpha converting enzyme (TACE), is a protease with sheddase activity.
• ADAM17 cleaves various non-matrix substrates, including cytokines, cytokine receptors, ErbB ligands, and adhesion proteins, impacting cellular signaling and inflammation.
• Dysregulated metalloproteinase activity is a hallmark of inflammatory autoimmune diseases.

Purpose of the Study:

• To elucidate the molecular mechanisms of ADAM17 in diseased conditions.
• To investigate the role of ADAM17 in regulating inflammation and autoimmunity.
• To explore how ADAM17 influences the progression of inflammatory processes in autoimmune diseases.

Main Methods:

• Review of recent experimental model systems.
• Analysis of studies investigating ADAM17-dependent cleavage of substrates in inflammatory diseases.
• Exploration of research on ADAM17's role in modulating inflammation and autoimmunity.

Main Results:

• ADAM17 modifies numerous non-matrix substrates crucial for inflammatory signaling.
• Experimental models are used to understand ADAM17's role in regulating signaling pathways and tissue interactions.
• Evidence suggests ADAM17 significantly influences the outcome of inflammation in autoimmune conditions.

Conclusions:

• ADAM17 plays a critical role in the pathogenesis of inflammatory autoimmune diseases.
• Further research into ADAM17's regulatory functions is essential for understanding and potentially treating autoimmune disorders.
• ADAM17 acts as a key modulator of inflammation in the context of autoimmunity.